Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tartrazine-containing drugs

W R Bartle

    Canadian Medical Association Journal
    |August 21, 1976
    PubMed
    Summary
    This summary is machine-generated.

    A survey identified 580 drug products containing tartrazine, a synthetic dye, from 156 Canadian pharmaceutical manufacturers. This information aids in managing patients sensitive to tartrazine.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy of allopurinol in single daily dose.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    Nontartrazine-containing drugs.

    Canadian Medical Association journal·2010
    Same author

    Seaweed, vitamin K, and warfarin.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2002
    Same author

    Grapefruit juice might still be factor in warfarin response.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1999
    Same author

    The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin.

    Journal of clinical pharmacology·1999
    Same author

    Diagnostic value of T cell reactivity in drug induced hepatitis.

    Gut·1999
    Same journal

    Tularaemia; a problem in diagnosis.

    Canadian Medical Association journal·2010
    Same journal

    CONTROL of cancer.

    Canadian Medical Association journal·2010
    Same journal

    Bilateral diphtheritic external otitis treated with sulfathiazole.

    Canadian Medical Association journal·2010
    Same journal

    Hypoplastic anaemia treated with transfusions and folic acid fraction.

    Canadian Medical Association journal·2010
    Same journal

    Lauron in rheumatoid arthritis; a further report.

    Canadian Medical Association journal·2010
    Same journal

    HOW the socialist looks at national health service in England.

    Canadian Medical Association journal·2010
    See all related articles

    Area of Science:

    • Pharmaceutical Science
    • Toxicology
    • Food Dyes

    Background:

    • Tartrazine (a pyrazole aniline dye) is used in various products.
    • Patient sensitivity to tartrazine necessitates identification of its sources.
    • Managing tartrazine-induced adverse reactions requires knowledge of product composition.

    Purpose of the Study:

    • To identify pharmaceutical products in Canada containing tartrazine.
    • To provide a comprehensive list of tartrazine-containing drugs for healthcare providers.
    • To assist in the clinical management of patients with tartrazine sensitivity.

    Main Methods:

    • A survey was conducted among pharmaceutical manufacturers in Canada.
    • Data collection occurred between December 1974 and March 1975.

    Related Experiment Videos

  • Information on drug products containing tartrazine was gathered from responding manufacturers.

    • Main Results:

    • 156 pharmaceutical manufacturers responded to the survey.
    • A list of approximately 580 drug products containing tartrazine was compiled.
    • The identified products represent a significant portion of the Canadian drug market at the time.

    Conclusions:

    • A substantial number of pharmaceutical products contained tartrazine during the survey period.
    • The compiled list is a valuable resource for identifying potential sources of tartrazine exposure in patients.
    • Healthcare providers can use this data to better manage patients with known tartrazine sensitivity.